Side-by-side comparison of AI visibility scores, market position, and capabilities
Harrison.ai is an Australian healthcare AI company building clinical-grade AI for radiology and pathology diagnostics; raised $129M+ AUD total at a $400M AUD valuation; its Annalise.ai radiology platform has FDA clearance and processes 5M+ studies;
Harrison.ai is a Sydney, Australia-based healthcare artificial intelligence company founded in 2018 by brothers Aengus and David Hallinan that builds clinical-grade AI models for diagnostic medicine, initially targeting radiology and pathology. The company''s flagship product — Annalise.ai — is a comprehensive AI platform for radiology interpretation that analyzes chest X-rays, CT scans, and other medical imaging studies to detect and flag a broad range of findings simultaneously. Unlike earlier radiology AI tools designed for single conditions, Annalise.ai is a multi-finding model trained to detect up to 124 findings in a single chest X-ray and 295 findings in chest CTs — providing a comprehensive AI second reader experience rather than a narrow single-disease detector.
Lark Health is a Mountain View-based AI-driven chronic disease prevention platform serving 30M+ covered lives via health plans and employers; raised $425M total including a $100M Series D; expanding into GLP-1 cost-containment in 2024–2025.
Lark Health is a healthcare technology company founded in 2011 and headquartered in Mountain View, California. It delivers AI-driven chronic disease prevention and management programs at scale, focused on conditions including diabetes (prevention and management), hypertension, weight management, and behavioral health. Lark's platform is deployed through a B2B2C model: health plans, self-insured employers, and Medicare Advantage plans contract with Lark to offer its digital coaching and monitoring tools to their members as a covered benefit, at no cost to the end user.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.